Abstract
We report the synthesis, characterization and cytotoxicity of six cyclometalated rhodium(III) complexes [Cp XRh(C ^N)Z] 0/+, in which Cp X = Cp*, Cp ph, or Cp biph, C ^N = benzo[h]quinoline, and Z = chloride or pyridine. Three X-ray crystal structures showing the expected “piano-stool” configurations have been determined. The chlorido complexes hydrolyzed faster in aqueous solution, and reacted preferentially with 9-ethyl guanine or glutathione compared to their pyridine analogues. The 1-biphenyl-2,3,4,5-tetramethylcyclopentadienyl complex [Cp biphRh(benzo-[h]quinoline)Cl] (3a) was the most efficient catalyst in coenzyme reduced nicotinamide adenine dinucleotide (NADH) oxidation to NAD + and induced an elevated level of reactive oxygen species (ROS) in A549 human lung cancer cells. The pyridine complex [Cp biphRh(benzo[h]quinoline)py] + (3b) was the most potent against A549 lung and A2780 ovarian cancer cell lines, being 5-fold more active than cisplatin towards A549 cells, and acted as a ROS scavenger. This work highlights a ligand-controlled strategy to modulate the reactivity and cytotoxicity of cyclometalated rhodium anticancer complexes.
Original language | English |
---|---|
Pages (from-to) | 1052-1060 |
Number of pages | 9 |
Journal | European Journal of Inorganic Chemistry |
Volume | 2020 |
Issue number | 11-12 |
Early online date | 20 Oct 2019 |
DOIs | |
Publication status | Published - 27 Mar 2020 |
Externally published | Yes |
Bibliographical note
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Publisher Copyright:
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Funder
Funding Information:This research was supported by the EPSRC (grant no. EP/P030572/1), Chancellor's International PhD Scholarships from the University of Warwick (for W.‐Y. Z. and H. S.), an EPSRC and Mike Enfys Bagguley PhD studentship for H. E. B, a Royal Society‐SERB Newton International Fellowship (NF151429 for S. B.), and the Wellcome Trust (209173/Z/17/Z for C. I.).
Funding Information:
This research was supported by the EPSRC (grant no. EP/P030572/1), Chancellor's International PhD Scholarships from the University of Warwick (for W.-Y. Z. and H. S.), an EPSRC and Mike Enfys Bagguley PhD studentship for H. E. B, a Royal Society-SERB Newton International Fellowship (NF151429 for S. B.), and the Wellcome Trust (209173/Z/17/Z for C. I.).
Keywords
- Antitumor agents
- Cyclopentadienyl ligands
- Cytotoxicity
- Reactive oxygen species
- Rhodium
ASJC Scopus subject areas
- Inorganic Chemistry